We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+42.28%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.23B
AUM Growth
-$42M
Cap. Flow
-$623M
Cap. Flow %
-19.3%
Top 10 Hldgs %
49.44%
Holding
136
New
22
Increased
36
Reduced
40
Closed
23

Top Buys

Rank Stock Value
1
SPRY icon
ARS Pharmaceuticals
SPRY
+$40.3M
2
SFT
Shift Technologies, Inc. Class A Common Stock
SFT
+$23.7M
3
MILE
Metromile, Inc. Common Stock
MILE
+$22.8M
4
IMAX icon
IMAX
IMAX
+$22.3M
5
KROS icon
Keros Therapeutics
KROS
+$16.2M

Top Sells

Rank Stock Value
1
WRLD icon
World Acceptance Corp
WRLD
+$22.4M
2
VAC icon
Marriott Vacations Worldwide
VAC
+$16.8M
3
INAQU
INSU Acquisition Corp. II Unit
INAQU
+$16.3M
4
FRG
Franchise Group, Inc.
FRG
+$15.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 24.66%
2 Consumer Discretionary 8.76%
3 Industrials 6.02%
4 Financials 5.59%
5 Technology 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUE icon
26
Cue Biopharma
CUE
$110M
$31.4M 0.97%
83,559
+5,485
+7% +$2.19M
SFT
27
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$31.3M 0.97%
378,840
+256,286
+209% +$23.7M
IMAX icon
28
IMAX
IMAX
$2.81B
$29.2M 0.9%
+1,618,281
New +$22.3M
FBIO icon
29
Fortress Biotech
FBIO
$91.4M
$27.5M 0.85%
578,727
+30,398
+6% +$1.32M
IMTX icon
30
Immatics
IMTX
$1.33B
$27.1M 0.84%
2,514,489
-107,675
-4% -$1.14M
FCFS icon
31
FirstCash
FCFS
$9.05B
$27.1M 0.84%
387,189
-44,380
-10% -$2.81M
WVE icon
32
Wave Life Sciences
WVE
$1.2B
$26.4M 0.82%
3,357,305
+978,879
+41% +$8.22M
MILE
33
DELISTED
Metromile, Inc. Common Stock
MILE
$26.4M 0.82%
+1,698,075
New +$22.8M
ALTG icon
34
Alta Equipment Group
ALTG
$237M
$25.7M 0.8%
2,600,012
+154,488
+6% +$1.33M
TFFP
35
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$25.3M 0.78%
70,539
-10,781
-13% -$4.15M
HCA icon
36
PUT
HCA Healthcare
HCA
$89.6B
$24.7M 0.76%
150,000
– –
CAR icon
37
CALL
Avis
CAR
$4.9B
$24.5M 0.76%
657,700
– –
UPLD icon
38
Upland Software
UPLD
$14.5M
$23M 0.71%
50,110
+2,258
+5% +$994K
THC icon
39
Tenet Healthcare
THC
$20.9B
$22.5M 0.7%
564,659
-217,566
-28% -$7.02M
BDSI
40
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$21.5M 0.67%
5,123,671
+57,716
+1% +$222K
EHTH icon
41
eHealth
EHTH
$40.4M
$21.2M 0.66%
299,734
+104,734
+54% +$7.96M
EXAS
42
PUT
DELISTED
Exact Sciences
EXAS
$19.9M 0.62%
150,000
– –
AKBA icon
43
Akebia Therapeutics
AKBA
$234M
$19.7M 0.61%
7,040,487
+1,293,864
+23% +$3.78M
EVRI
44
DELISTED
Everi Holdings
EVRI
$18.8M 0.58%
1,363,786
-177,266
-12% -$1.93M
JYNT icon
45
The Joint Corp
JYNT
$123M
$18.2M 0.56%
693,172
-155,709
-18% -$3.56M
AKU
46
DELISTED
Akumin Inc
AKU
$17.4M 0.54%
5,784,556
+100,844
+2% +$338K
AVTX icon
47
Avalo Therapeutics
AVTX
$1.06B
$16.5M 0.51%
2,164
+153
+8% +$1.06M
CRHM
48
DELISTED
CRH Medical Corporation
CRHM
$16.1M 0.5%
6,892,005
+114,100
+2% +$280K
SYRE icon
49
Spyre Therapeutics
SYRE
$9.29B
$15.5M 0.48%
78,972
-45,965
-37% -$9.53M
VMD icon
50
Viemed Healthcare
VMD
$355M
$15.2M 0.47%
1,951,480
+453,380
+30% +$3.99M
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Nantahala Capital Management held 136 positions worth $3.23B, down 1.3% from $3.27B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Nantahala Capital Management withdrew a net $623M in Q4 2020, closing 23 positions and reducing 40 holdings. Its most notable exit was World Acceptance Corp, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in ARS Pharmaceuticals worth $54.4M.

  • Nantahala Capital Management's largest Q4 2020 buy was ARS Pharmaceuticals: 1,206,471 shares worth $54.4M.
  • Nantahala Capital Management added most to Shift Technologies, Inc. Class A Common Stock in Q4 2020, an estimated $23.7M increase.
  • Nantahala Capital Management's biggest Q4 2020 reduction was Marriott Vacations Worldwide, cutting an estimated $16.8M.
  • Nantahala Capital Management fully exited World Acceptance Corp in Q4 2020, selling an estimated $22.4M.
  • Nantahala Capital Management's ten largest holdings make up 49% of its $3.23B portfolio in Q4 2020.
  • Nantahala Capital Management opened 22 new positions and closed 23 in Q4 2020.
  • Nantahala Capital Management's portfolio value fell 1.3% quarter-over-quarter to $3.23B.

Based on Nantahala Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.